Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Racial Disparities in Cell of Origin Among DLBCL Patients.

Christopher R. Flowers, MD, Loretta Nastoupil, MD, Uma Borate, MD, MS, Pareen J Shenoy, MBBS, MPH, Will Donnellan, Nassoma King, PA, Kevin Bumpers, MHA, Mary Jo Lechowicz, MD, Leon Bernal-Mizrachi, M.D., Rajni Sinha, MD, MRCP, Elizabeth Chastain, MD, Kevin E Fisher, M.D., Ph.D., James M. Foran, MD, FRCPC, Vishnu Reddy, MD, David L Jaye, MD

Blood (2012) 120 (21): 2686.

https://doi.org/10.1182/blood.V120.21.2686.2686

Published: 2012

Journal Articles

Consolidation with High Dose Therapy and Autologous Stem Cell Transplant Improves Survival for Patients with Mantle Cell Lymphoma

Loretta Nastoupil, MD, Pareen J Shenoy, MBBS, MPH, Alex Ambinder, Miray Seward, Ajay K. Nooka, MD, MPH, FACP, Edmund K. Waller, MD, PhD, Amelia Langston, MD, Jonathan L. Kaufman, MD, Nassoma King, PA, Mary Jo Lechowicz, MD, Sagar Lonial, MD, Rajni Sinha, MD, MRCP, Christopher R. Flowers, MD

Blood (2012) 120 (21): 2006.

https://doi.org/10.1182/blood.V120.21.2006.2006

Published: 2012

Journal Articles

A Systematic Review and Meta-Analysis of Radioimmunotherapy Consolidation for Untreated Patients with Follicular Lymphoma (FL)

Adam C. Rose, Gia Garrett, Miray Seward, Pareen J Shenoy, MBBS, MPH, Roy A Kucuk, Hannah Doksansky, Christopher R Flowers, MD

Blood (2011) 118 (21): 101.

https://doi.org/10.1182/blood.V118.21.101.101

Published: 2011

Journal Articles

Vinorelbine, Paclitaxel, Etoposide, Cisplatin and Cytarabine (VTEPA) Is An Effective Salvage Therapy for Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) but Not for R/R Diffuse Large B Cell Lymphoma (DLBCL)

Rajni Sinha, MD, MRCP, Nassoma King, PA, Pareen J Shenoy, MBBS, MPH, Mary Jo Lechowicz, MD, Kevin Bumpers, MHA, Donald Hutcherson, Martha Arellano, MD, Amelia Langston, MD, Jonathan L. Kaufman, MD, Leonard T. Heffner, MD, Edmund K Waller, MD PhD, Christopher R Flowers, MD, Sagar Lonial, MD

Blood (2011) 118 (21): 1628.

https://doi.org/10.1182/blood.V118.21.1628.1628

Published: 2011

Journal Articles

Examining the Racial Disparities In Presentation and Treatment for Patients with Diffuse Large B-Cell Lymphoma (DLBCL).

Pareen J Shenoy, MBBS, MPH, Uma Borate, MD, MS, Kevin Bumpers, MHA, Tanyanika Douglas-Holland, MD, Nassoma King, PA, Mary Jo Lechowicz, MD, David L Jaye, MD, Will Donnellan, MD, Angelina The, MD, BS, Vishnu Reddy, MD, James M. Foran, MD, FRCPC, Christopher R Flowers, MD, MS

Blood (2010) 116 (21): 1521.

https://doi.org/10.1182/blood.V116.21.1521.1521

Published: 2010

Journal Articles

Use of Rituximab with CHOP Chemotherapy Appears to Overcome Racial Disparities In Survival In Black Patients with Diffuse Large B Cell Lymphoma When Compared to CHOP Chemotherapy Alone.

Uma Borate, MD, MS, Pareen J Shenoy, MBBS, MPH, Will Donnellan, Kevin Bumpers, MHA, Tanyanika Douglas-Holland, MD, Nassoma King, PA, Mary Jo Lechowicz, MD, Angelina The, MD, BS, David L Jaye, MD, Vishnu Reddy, Christopher R Flowers, MD, MS, James M. Foran, MD, FRCPC

Blood (2010) 116 (21): 1528.

https://doi.org/10.1182/blood.V116.21.1528.1528

Published: 2010

Journal Articles

Black/White Differences in the Treatment and Outcomes of Diffuse Large B Cell Lymphoma: A Matched Cohort Analysis.

Pareen J. Shenoy, MBBS, MPH, Kevin Bumpers, MPA, Nassoma King, PA, Taoying Huang, MS, Neha Malik, Rajni Sinha, MD, MRCP, Christopher R. Flowers, MD

Blood (2009) 114 (22): 1392.

https://doi.org/10.1182/blood.V114.22.1392.1392

Published: 2009

Journal Articles

Racial Differences in the Presentation and Outcomes of Diffuse Large B-Cell Lymphoma in the United States.

Neha Malik, Pareen J. Shenoy, MBBS, MPH, Kevin Bumpers, MPA, Rajni Sinha, MD, MRCP, Christopher R. Flowers, MD

Blood (2009) 114 (22): 898.

https://doi.org/10.1182/blood.V114.22.898.898

Published: 2009

Journal Articles

Imatinib Mesylate and Hyper-CVAD (IM-HCVAD) for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL).

Martha Arellano, MD, Disni Muringampurath-John, MD, Pareen J. Shenoy, MBBS, MPH, Elliott F. Winton, MD, Beverly Bryan, Amelia Langston, MD, Rajni Sinha, MD, MRCP, Morgan L. McLemore, MD, Leonard Heffner, MD, H. Jean Khoury, MD

Blood (2009) 114 (22): 4103.

https://doi.org/10.1182/blood.V114.22.4103.4103

Published: 2009

Journal Articles

The Addition of Bortezomib to Modified R-CHOP as Initial Therapy for Follicular NHL Results in High CR Rate and Is Well Tolerated.

Rajni Sinha, MD, MRCP, Jonathan L. Kaufman, MD, Hanna Jean Khoury, Jr., MD, Nassoma King, PA, Pareen J. Shenoy, MBBS, MPH, Carol Lewis, Kevin Bumpers, MPA, Sagar Lonial, MD, Christopher R. Flowers, MD

Blood (2009) 114 (22): 3718.

https://doi.org/10.1182/blood.V114.22.3718.3718

Published: 2009

Journal Articles

Examining Decision Making Styles in Patients with Sickle Cell Disease (SCD) Regarding Allogeneic Stem Cell Tranplantation (ASCT)

Olabunmi A. Agboola, Pareen J. Shenoy, MBBS, MPH, Paula J. Edwards, Ph.D., James R. Eckman, MD, Christopher R. Flowers, MD

Blood (2008) 112 (11): 168.

https://doi.org/10.1182/blood.V112.11.168.168

Published: 2008

Journal Articles

Lymphoma and Whole Body CT Scan Mortality Risk

Pareen J. Shenoy, MBBS, MPH, Tulasi Gude, Rajni Sinha, MD, Christopher R. Flowers, MD

Blood (2008) 112 (11): 1321.

https://doi.org/10.1182/blood.V112.11.1321.1321

Published: 2008

NARROW

Racial Disparities in Cell of Origin Among DLBCL Patients.

Consolidation with High Dose Therapy and Autologous Stem Cell Transplant Improves Survival for Patients with Mantle Cell Lymphoma

A Systematic Review and Meta-Analysis of Radioimmunotherapy Consolidation for Untreated Patients with Follicular Lymphoma (FL)

Vinorelbine, Paclitaxel, Etoposide, Cisplatin and Cytarabine (VTEPA) Is An Effective Salvage Therapy for Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) but Not for R/R Diffuse Large B Cell Lymphoma (DLBCL)

Examining the Racial Disparities In Presentation and Treatment for Patients with Diffuse Large B-Cell Lymphoma (DLBCL).

Use of Rituximab with CHOP Chemotherapy Appears to Overcome Racial Disparities In Survival In Black Patients with Diffuse Large B Cell Lymphoma When Compared to CHOP Chemotherapy Alone.

Black/White Differences in the Treatment and Outcomes of Diffuse Large B Cell Lymphoma: A Matched Cohort Analysis.

Racial Differences in the Presentation and Outcomes of Diffuse Large B-Cell Lymphoma in the United States.

Imatinib Mesylate and Hyper-CVAD (IM-HCVAD) for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL).

The Addition of Bortezomib to Modified R-CHOP as Initial Therapy for Follicular NHL Results in High CR Rate and Is Well Tolerated.

Examining Decision Making Styles in Patients with Sickle Cell Disease (SCD) Regarding Allogeneic Stem Cell Tranplantation (ASCT)

Lymphoma and Whole Body CT Scan Mortality Risk

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only